Cystic fibrosis and exocrine pancreatic insufficiency

J 2019

Cystic fibrosis and exocrine pancreatic insufficiency

TESAŘÍKOVÁ, Pavla, Lumír KUNOVSKÝ, Jan TRNA, Petr DÍTĚ, Petr JABANDŽIEV et. al.

Základní údaje

Originální název

Cystic fibrosis and exocrine pancreatic insufficiency

Název česky

Cystická fibróza a exokrinní pankreatická insuficience

Autoři

TESAŘÍKOVÁ, Pavla (203 Česká republika), Lumír KUNOVSKÝ (203 Česká republika, domácí), Jan TRNA (203 Česká republika, domácí), Petr DÍTĚ (203 Česká republika, domácí), Petr JABANDŽIEV (203 Česká republika, domácí), Jitka VACULOVÁ (203 Česká republika, domácí) a Zdeněk KALA (203 Česká republika, domácí)

Vydání

Gastroenterologie a Hepatologie, Ambit Media a.s. 2019, 1804-7874

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Kód RIV

RIV/00216224:14110/19:00110723

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.14735/amgh2019303

Klíčová slova anglicky

CFTR; cystic fibrosis; exocrine pancreatic insufficiency; malnutrition; pancreatitis

Štítky

rivok

Změněno: 15. 3. 2021 11:26, Mgr. Tereza Miškechová

Anotace

V originále

Cystic fibrosis (CF) is a genetic disease affecting many organs, including the gastrointestinal tract. While the pulmonary damage is the most life threatening, the pancreas is one of the first organs affected by CF and one of the most strongly affected. Mutation in the CF transmembrane conductance regulator (CFTR) gene results in a reduced volume of pancreatic juice and hyperconcentration of macromolecules leading to precipitation in the duct lumina, causing obstruction and damage. The clinical presentation of individual cases depends on a combination of different CFTR mutations, the potential presence of modifier gene mutations and environmental factors. CFTR mutations are historically divided into 5 classes – severe mutations (classes 1–3) and mild mutations (classes 4–5). The CFTR functional status depends on the combined effects of both CFTR allels and the severity of the phenotype depends on the milder mutation. The majority of CF patients exhibit exocrine pancreatic insufficiency in early childhood because functional acinar tissue has been lost in utero or soon after birth. These patients rarely suffer from pancreatic complications such as recurrent acute pancreatitis and/or chronic pancreatitis which, however, can occur in the minority of patients who possess residual pancreatic exocrine function. CFTR mutations are found more frequently in idiopathic and alcoholic chronic pancreatitis but the data is conflicting. A combination with serine protease inhibitor Kazal-type 1 (SPINK-1) mutations can be found in the idiopathic chronic pancreatitis group, as well as the presence of environmental factors. Malnutrition is directly related to a worse prognosis of CF patients and the delivery of active digestive enzymes is a cornerstone of treatment, with acid supression and vitamin supplementation playing an important additional role.

Citovat

TESAŘÍKOVÁ, Pavla, Lumír KUNOVSKÝ, Jan TRNA, Petr DÍTĚ, Petr JABANDŽIEV, Jitka VACULOVÁ a Zdeněk KALA. Cystic fibrosis and exocrine pancreatic insufficiency. Gastroenterologie a Hepatologie. Ambit Media a.s., 2019, roč. 73, č. 4, s. 303-307. ISSN 1804-7874. Dostupné z: https://dx.doi.org/10.14735/amgh2019303.

@article{1559196,
   author = {Tesaříková, Pavla and Kunovský, Lumír and Trna, Jan and Dítě, Petr and Jabandžiev, Petr and Vaculová, Jitka and Kala, Zdeněk},
   article_number = {4},
   doi = {http://dx.doi.org/10.14735/amgh2019303},
   keywords = {CFTR; cystic fibrosis; exocrine pancreatic insufficiency; malnutrition; pancreatitis},
   language = {eng},
   issn = {1804-7874},
   journal = {Gastroenterologie a Hepatologie},
   title = {Cystic fibrosis and exocrine pancreatic insufficiency},
   url = {http://www.csgh.info/en/article/cystic-fibrosis-and-exocrine-pancreatic-insufficiency-},
   volume = {73},
   year = {2019}
}

TY  - JOUR
ID  - 1559196
AU  - Tesaříková, Pavla - Kunovský, Lumír - Trna, Jan - Dítě, Petr - Jabandžiev, Petr - Vaculová, Jitka - Kala, Zdeněk
PY  - 2019
TI  - Cystic fibrosis and exocrine pancreatic insufficiency
JF  - Gastroenterologie a Hepatologie
VL  - 73
IS  - 4
SP  - 303-307
EP  - 303-307
PB  - Ambit Media a.s.
SN  - 18047874
KW  - CFTR
KW  - cystic fibrosis
KW  - exocrine pancreatic insufficiency
KW  - malnutrition
KW  - pancreatitis
UR  - http://www.csgh.info/en/article/cystic-fibrosis-and-exocrine-pancreatic-insufficiency-
L2  - http://www.csgh.info/en/article/cystic-fibrosis-and-exocrine-pancreatic-insufficiency-
N2  - Cystic fibrosis (CF) is a genetic disease affecting many organs, including the gastrointestinal tract. While the pulmonary damage is the most life threatening, the pancreas is one of the first organs affected by CF and one of the most strongly affected. Mutation in the CF transmembrane conductance regulator (CFTR) gene results in a reduced volume of pancreatic juice and hyperconcentration of macromolecules leading to precipitation in the duct lumina, causing obstruction and damage. The clinical presentation of individual cases depends on a combination of different CFTR mutations, the potential presence of modifier gene mutations and environmental factors. CFTR mutations are historically divided into 5 classes – severe mutations (classes 1–3) and mild mutations (classes 4–5). The CFTR functional status depends on the combined effects of both CFTR allels and the severity of the phenotype depends on the milder mutation. The majority of CF patients exhibit exocrine pancreatic insufficiency in early childhood because functional acinar tissue has been lost in utero or soon after birth. These patients rarely suffer from pancreatic complications such as recurrent acute pancreatitis and/or chronic pancreatitis which, however, can occur in the minority of patients who possess residual pancreatic exocrine function. CFTR mutations are found more frequently in idiopathic and alcoholic chronic pancreatitis but the data is conflicting. A combination with serine protease inhibitor Kazal-type 1 (SPINK-1) mutations can be found in the idiopathic chronic pancreatitis group, as well as the presence of environmental factors. Malnutrition is directly related to a worse prognosis of CF patients and the delivery of active digestive enzymes is a cornerstone of treatment, with acid supression and vitamin supplementation playing an important additional role.
ER  -

TESAŘÍKOVÁ, Pavla, Lumír KUNOVSKÝ, Jan TRNA, Petr DÍTĚ, Petr JABANDŽIEV, Jitka VACULOVÁ a Zdeněk KALA. Cystic fibrosis and exocrine pancreatic insufficiency. \textit{Gastroenterologie a Hepatologie}. Ambit Media a.s., 2019, roč.~73, č.~4, s.~303-307. ISSN~1804-7874. Dostupné z: https://dx.doi.org/10.14735/amgh2019303.

Podrobný výpis o publikaci